tiprankstipranks
Advertisement
Advertisement
Avalo Therapeutics to join Russell 2000, Russell 3000
PremiumThe FlyAvalo Therapeutics to join Russell 2000, Russell 3000
2M ago
Avalo Therapeutics Adds Independent Director Ron Philip
Premium
Company Announcements
Avalo Therapeutics Adds Independent Director Ron Philip
2M ago
Avalo Therapeutics Expands Pipeline With New IL-1β Antibody
Premium
Company Announcements
Avalo Therapeutics Expands Pipeline With New IL-1β Antibody
2M ago
Avalo Therapeutics Shareholders Back Directors and Governance Changes
PremiumCompany AnnouncementsAvalo Therapeutics Shareholders Back Directors and Governance Changes
3M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
3M ago
Avalo Therapeutics price target lowered to $34 from $40 at Wedbush
Premium
The Fly
Avalo Therapeutics price target lowered to $34 from $40 at Wedbush
3M ago
Avalo Therapeutics reports Q1 EPS (98c), consensus ($1.01)
PremiumThe FlyAvalo Therapeutics reports Q1 EPS (98c), consensus ($1.01)
3M ago
Avalo Therapeutics price target raised to $60 from $48 at Piper Sandler
Premium
The Fly
Avalo Therapeutics price target raised to $60 from $48 at Piper Sandler
3M ago
Avalo Therapeutics Announces Major Equity and Warrant Offering
Premium
Company Announcements
Avalo Therapeutics Announces Major Equity and Warrant Offering
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100